Sidebar

  • Magazine
  • Events
  • Videos
  • Gallery
  • Blog
  • Gantry Home

Magazine menu

  • Home
  • News
    • China News
    • Religion
  • lifestyle
  • Tech
  • Financial
  • Military
  • Entertainment
  • Politics
  • Health
  • Sport
  • Environment
  • Opinion
  • Weather
  • Podcasts
  • Video
  • Ads
The Power of Truth®
Friday, May 23, 2025
Friday, May 23, 2025
  • Home
  • News
    • China News
    • Religion
  • lifestyle
  • Tech
  • Financial
  • Military
  • Entertainment
  • Politics
  • Health
  • Sport
  • Environment
  • Opinion
  • Weather
  • Podcasts
  • Video
  • Ads
  1. You are here:  
  2. Health

A new tuberculosis vaccine candidate recombinant protein with additional post-translational modifications occurring in Mycobacterium tuberculosis cells

Details
Staff logo
19 June 2024
Health
  • Previous Article More effective cancer treatment with iontronic pump
  • Next Article Treatment for autoimmune disorder acts on balance of immune cell types
Tuberculosis is a serious health threat, and the efficacy of the BCG vaccine against tuberculosis diminishes in adulthood, making booster vaccines a realistic option. Mycobacterial DNA-binding protein 1 (MDP1), a protein found in Mycobacterium tuberculosis, elicits higher protective IFN-gamma responses in individuals who suppress tuberculosis, thus making it a vaccine candidate.
Tuberculosis is a serious health threat, and the efficacy of the BCG vaccine against tuberculosis diminishes in adulthood, making booster vaccines a realistic option. Mycobacterial DNA-binding protein 1 (MDP1), a protein found in Mycobacterium tuberculosis, elicits higher protective IFN-gamma responses in individuals who suppress tuberculosis, thus making it a vaccine candidate.

Read more https://www.sciencedaily.com/releases/2024/06/240619143640.htm

  • Previous Article More effective cancer treatment with iontronic pump
  • Next Article Treatment for autoimmune disorder acts on balance of immune cell types

HUNGRY FOR TRUTH?  FEED THE NEED.

The Power of Truth®
  • Cookies Policy
  • Privacy Policy
  • Terms of Use
  • Contact
Copyright © 2025 Joomla!. All Rights Reserved. Powered by The Power of Truth® - Designed by JoomlArt.com. Bootstrap is a front-end framework of Twitter, Inc. Code licensed under Apache License v2.0. Font Awesome font licensed under SIL OFL 1.1.